Kaneka Medical America LLC
Clinical trials sponsored by Kaneka Medical America LLC, explained in plain language.
A subsidiary of Kaneka Corporation, providing medical devices and materials.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New coil procedure aims to stop brain clots from returning Results expected Nov 2026 (estimated)
- Can a blood filter help mothers with severe preeclampsia carry longer? Results expected Aug 2027 (estimated)
-
Can a blood filter help mothers with severe preeclampsia carry longer?
Disease control Not yet recruitingThis trial tests whether a device called the KNP-1000 apheresis system is safe for pregnant women with severe preeclampsia and their babies. The device filters the mother's blood to remove a protein linked to the condition. Researchers will enroll about 13 women between 23 and 32…
Sponsor: Kaneka Medical America LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New coil procedure aims to stop brain clots from returning
Disease control Not yet recruitingThis study tests a new device called the i-ED COIL for treating chronic subdural hematoma, a blood clot on the brain. About 200 participants will undergo a minimally invasive procedure to place the coil, sometimes along with standard surgery to drain the clot. The goal is to see …
Sponsor: Kaneka Medical America LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC